Santiago Ortega Gutierrez, MD
Vascular & Interventional Radiology · Iowa City, IANPI 1629148010
Payments from drug & device makers
Across 474 payments — averaging $2580.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$705K
- Medtronic$224K
- Siemens Medical Solutions USA, Inc.$187K
- Microvention, Inc.$51K
- Route 92 Medical, Inc.$33K
- Medical Device Business Services, Inc.$22K
- plus $957 from 6 others
Across 1 payment — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Microvention, Inc.$5K
What the payments were for
- Consulting fees$356,27157%
- Speaking & faculty fees$172,85028%
- Travel & lodging$91,46615%
- Food & beverage$7,9031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 308 | $704,972 |
| Medtronic(2 entities) | 132 | $223,745 |
| Siemens Medical Solutions USA, Inc. | 11 | $187,137 |
| Microvention, Inc. | 6 | $51,273 |
| Route 92 Medical, Inc. | 3 | $33,207 |
| Medical Device Business Services, Inc. | 6 | $21,952 |
| Viz.ai, Inc. | 2 | $611 |
| Sirtex Medical Inc | 1 | $157 |
| Johnson & Johnson | 1 | $91 |
| Balt USA, LLC | 2 | $56 |
| Imperative Care, Inc | 1 | $35 |
| Asahi Intecc USA, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Pipeline$179,924
- SURPASS EVOLVE$176,039
- SURPASS$124,987
- TARGET$50,228
- BROADWAY 8$32,400
- SYNCHRO SELECT$25,900
- EVOLVE PROLINE$15,438
- SALVATION$15,150
- AXS CATALYST 7$14,589
- EMBOGUARD$13,910
- INFINITY$13,200
- NEUROFORM EZ 3$13,175
- TREVO$12,738
- AXS VECTA 71$12,600
- SPOTLIGHT$8,025
- ERIC RETRIEVAL DEVICE$5,000
- 1488, IDEAL EYES$2,812
- AXS INFINITY LS$1,700
- AVS ANCHOR-C$1,460
- POWER-PRO$1,447
How this compares
$1,223,244 in reported general payments places this provider in the 95th percentile of 34 vascular & interventional radiology providers in Iowa.
See all vascular & interventional radiology providers in Iowa →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 21 | $12,537 |
| ClopidogrelClopidogrel Bisulfate | 27 | $213 |
| Atorvastatin Calcium | 22 | $202 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Iowa City
- Edgar SamaniegoIowa City$1.2M
- Sandeep LaroiaIowa City$24K
- Douglas PowellIowa City$16K
- Gustavo AndradeIowa City$13K
- Chad DavisIowa City$6K
- Bradford OlivaIowa City$3K
- Brendan CarneyIowa City$2K
- Talal MouradIowa City$2K
- Hans BindnerIowa City$1K
- Jerry KovoorIowa City$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.